Shigematsu Works Co (TSE:7980) EBITDA Margin %: 16.05% (As of Mar. 2026) — 48% Above Median


TSE:7980 Shigematsu Works Co Ltd TSE:7980
80 GF Score
Price 円810.00
GF Value 円946.81
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Shigematsu Works Co EBITDA Margin %?

Shigematsu Works Co TSE:7980 -1.10% 80 EBITDA Margin % is 16.05% as of Mar. 2026, which is 48% above its 10-year median of 10.85. GuruFocus rates TSE:7980 with a GF Score™ of 80/100 and a GF Value™ of 円946.81 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 813 Medical Devices & Instruments companies, Shigematsu Works Co ranks better than 59.66% on this metric.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Shigematsu Works Co's EBITDA for the six months ended in Mar. 2026 was 円1,477 Mil. Shigematsu Works Co's Revenue for the six months ended in Mar. 2026 was 円9,203 Mil. Therefore, Shigematsu Works Co's EBITDA margin for the quarter that ended in Mar. 2026 was 16.05%.


Shigematsu Works Co  (TSE:7980) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Shigematsu Works Co EBITDA Margin % Related Terms


Shigematsu Works Co EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Shigematsu Works Co's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Shigematsu Works Co EBITDA Margin % Chart

Shigematsu Works Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.31 13.75 10.66 12.58 12.27

Shigematsu Works Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12.89 9.60 14.95 6.82 16.05

TSE:7980 vs ISRG, BDX, MDLN: EBITDA Margin % Comparison

For the Medical Instruments & Supplies subindustry, Shigematsu Works Co's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Shigematsu Works Co EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Shigematsu Works Co's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Shigematsu Works Co's EBITDA Margin % falls into.


TSE:7980
80GF Score
Shigematsu Works Co Ltd TSE:7980
EBITDA Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Shigematsu Works Co EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Shigematsu Works Co's EBITDA Margin % for the fiscal year that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (A: Mar. 2026 )/Revenue (A: Mar. 2026 )
=1912.649/15593.485
=12.27 %

Shigematsu Works Co's EBITDA Margin % for the quarter that ended in Mar. 2026 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=1476.606/9202.861
=16.05 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of 16.05% mean?
Shigematsu Works Co (TSE:7980) has a EBITDA Margin % of 16.05% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shigematsu Works Co and its competitors. This is 48% above median its historical median of 10.85. Over the past decade, Shigematsu Works Co's EBITDA Margin % has ranged from 6.28 to 13.75. According to the industry distribution chart, Shigematsu Works Co ranks #328 out of 813 companies in the Medical Devices & Instruments industry, placing it in the top 40.3%.
Is Shigematsu Works Co's EBITDA Margin % too high?
Shigematsu Works Co's current EBITDA Margin % of 16.05% is 48% above median its 10-year median of 10.85. Over the past 10 years, this metric has ranged from a low of 6.28 to a high of 13.75. The Medical Devices & Instruments industry median EBITDA Margin % is 7.48. Shigematsu Works Co's value of 16.05% is 114.6% above this industry median. Based on the distribution chart, Shigematsu Works Co ranks #328 out of 813 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Shigematsu Works Co has a GF Score™ of 80/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Shigematsu Works Co's EBITDA Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Shigematsu Works Co ranks #328 out of 813 companies for EBITDA Margin %. This puts Shigematsu Works Co in the upper half of its industry. The industry median EBITDA Margin % is 7.48. Shigematsu Works Co's value of 16.05% is 114.6% above this benchmark. Historically, Shigematsu Works Co's own EBITDA Margin % has ranged from 6.28 to 13.75 over the past decade. While the company's 10-year median is 10.85 vs. the industry median of 7.48, Shigematsu Works Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 813 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shigematsu Works Co's current EBITDA Margin % of 16.05% is 114.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Shigematsu Works Co and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shigematsu Works Co's current EBITDA Margin % is 16.05%, which is 48% above median its own 10-year median of 10.85. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shigematsu Works Co stock overvalued right now?
Based on GuruFocus' analysis, Shigematsu Works Co (TSE:7980) is currently considered Modestly Undervalued. The stock's GF Value™ is 円946.81, compared to a current price of 円810.00 — trading 14.4% below its estimated fair value. The current EBITDA Margin % is 16.05%, which is 48% above median its 10-year median of 10.85 and 114.6% above the Medical Devices & Instruments industry median of 7.48. Shigematsu Works Co's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Shigematsu Works Co (TSE:7980), the current EBITDA Margin % is 16.05% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Shigematsu Works Co (TSE:7980) Overvalued in 2026?

Based on GuruFocus' analysis, Shigematsu Works Co stock appears to be undervalued. The current stock price of 円810.00 is trading 14.4% below its estimated GF Value™ of 円946.81. GuruFocus considers Shigematsu Works Co to be Modestly Undervalued.

Key valuation signals for TSE:7980:

  • EBITDA Margin %: 16.05% (48% above median its 10-year median of 10.85)
  • GF Value™: 円946.81 vs. price of 円810.00 (14.4% below fair value)
  • GF Score™: 80/100 with 4 warning signs
  • Industry Position: 114.6% above the Medical Devices & Instruments median (#328 of 813)

No single metric tells the full story. See the TSE:7980 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Shigematsu Works Co Business Description

Address 1-26-1, Nishigahara, Kita-ku, Tokyo, JPN, 114 0024
Shigematsu Works Co Ltd is a Japan based company engaged in the safety business. It manufactures personal and respiratory protective devices related to fire and industrial safety, equipment for air purifying, emergency and rescue operations. The company offers products such as gas respirators, chemical cartridge respirators, particulate respirators, self-contained breathing apparatus, powered air-purifying respirators, supplied-air respirators, eye protector, face shields, earmuffs, safety belts, protective clothing, protective gloves, stretchers, oxygen meters and other related products. The products offered by the organization has application in various industries including textile, chemical, automobile, fishery, mining, warehouse and others.
80GF Score

Get the complete analysis for TSE:7980

EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円810.00
Price
円946.81
GF Value